Tsontcho Ianchulev - Jun 27, 2023 Form 4 Insider Report for EYENOVIA, INC. (EYEN)

Role
Director
Signature
/s/ Tsontcho Ianchulev
Stock symbol
EYEN
Transactions as of
Jun 27, 2023
Transactions value $
$0
Form type
4
Date filed
6/29/2023, 06:41 PM
Previous filing
May 2, 2023
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYEN Common Stock, par value $.0001 Award $0 +17.2K +5.21% $0.00 348K Jun 27, 2023 Direct F1
holding EYEN Common Stock, par value $.0001 607K Jun 27, 2023 By Private Medical Equity, Inc. F2
holding EYEN Common Stock, par value $.0001 6K Jun 27, 2023 By The Meliora Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYEN Stock Option (right to buy) Award $0 +24.7K $0.00 24.7K Jun 27, 2023 Common Stock 24.7K $2.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that fully vest on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.
F2 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The option becomes exercisable on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.